Spectrum Pharmaceuticals, Inc. to Present Corporate Update at 31st Annual J.P. Morgan Healthcare Conference in San Francisco on January 9th

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the 31st Annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco. The Company presentation is on Wednesday, January 9, 2013, at 7:30 AM PT.